When is the ideal time to remove cerclage in cases requiring cesarean hysterectomy for placenta accreta spectrum?
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20190972Keywords:
Cerclage, Placenta accreta spectrum, Placenta previa, RemoveAbstract
Placenta accreta spectrum (PAS) presents one of the highest risks to pregnancy and often requires a cesarean hysterectomy for management, but the challenges associated with this surgery often cause severe obstetric haemorrhaging and high rates of maternal morbidity. Shirodkar cerclage is usually performed in cases with cervical insufficiency, a short cervix with previous preterm birth, etc., to decrease the preterm birth rate. It is recommended that Shirodkar cerclage is removed when the patient approaches term, but the ideal timing of removal for patient for whom cesarean hysterectomy is planned is not clear. Here, authors present a case of PAS in whom Shirodkar cerclage that was difficult to remove at the timing of cesarean hysterectomy. After cesarean hysterectomy, the patient had a vaginal abscess and required antibiotic therapy for approximately two weeks. In the light of our case, authors discuss the timing of removal of cerclage in the cases of PAS.
References
Silver RM. Abnormal Placentation: Placenta Previa, Vasa Previa, and Placenta Accreta. Obstet Gynecol. 2015;126(3):654-68.
Yamada T, Hirahata E, Ihara N, Nishimura D, Inoue K, Kato J, Nagata H, Minamishima S, Morisaki H. Cesarean hysterectomy in a hybrid operating room for placenta percreta: a report of three cases. JA Clinic Rep. 2019;5(1):9.
Tanaka M, Matsuzaki S, Matsuzaki S, Kakigano A, Kumasawa K, Ueda Y, Endo M, Kimura T. Placenta accreta following hysteroscopic myomectomy. Clinic Case Rep. 2016;4(6):541.
Jauniaux E, Bunce C, Grønbeck L, Langhoff-Roos J. Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis. Am J Obstet Gynecol. 2019.
Jauniaux E, Ayres-de-Campos D, Diagnosis FPA, Management Expert Consensus P. FIGO consensus guidelines on placenta accreta spectrum disorders: Introduction. Int J Gynaecol Obstet. 2018;140(3):261-4.
Ehsanipoor RM, Seligman NS, Saccone G, Szymanski LM, Wissinger C, Werner EF, et al. Physical Examination-Indicated Cerclage: A Systematic Review and Meta-analysis. Obstet Gynecol. 2015;126(1):125-35.
Berghella V, Ludmir J, Simonazzi G, Owen J. Transvaginal cervical cerclage: evidence for perioperative management strategies. Am J Obstet Gynecol. 2013;209(3):181-92.
Allen L, Jauniaux E, Hobson S, Papillon-Smith J, Belfort MA, Diagnosis FPA, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management. Int J Gynaecol Obstet. 2018;140:281-90.
Matsuzaki S, Yoshino K, Kajimoto E, Tanaka Y, Mimura K, Kanagawa T, Kimura T. Successful management of placenta percreta by cesarean hysterectomy with transverse uterine fundal incision. Int J Reprod Contracept Obstet Gynecol. 2014;3(2):447-9.
Matsuzaki S, Yoshino K, Mimura K, Kanagawa T, Kimura T. Cesarean delivery via a transverse uterine fundal incision for the successful management of a low-lying placenta and aplastic anemia. Clin Exp Obstet Gynecol. 2016;43(6):262-4.
Matsuzaki S, Yoshino K, Kumasawa K, Satou N, Mimura K, Kanagawa T, et al. Placenta percreta managed by transverse uterine fundal incision with retrograde cesarean hysterectomy: a novel surgical approach. Clin Case Rep. 2014;2(6):260-4.
Berghella V, Ciardulli A, Rust OA, To M, Otsuki K, Althuisius S, et al. Cerclage for sonographic short cervix in singleton gestations without prior spontaneous preterm birth: systematic review and meta-analysis of randomized controlled trials using individual patient-level data. Ultrasound Obstet Gynecol. 2017;50(5):569-77.
American College of O, Gynecologists. ACOG Practice Bulletin No.142: Cerclage for the management of cervical insufficiency. Obstet Gynecol. 2014;123(2 Pt 1):372-9.
Sentilhes L, Goffinet F, Kayem G. Management of placenta accreta. Acta Obstet Gynecol Scand. 2013;92(10):1125-34.
Hoffman MS, Roberts WS, Fiorica JV, Angel JL, Finan MA, Cavanagh D. Elective cesarean hysterectomy for treatment of cervical neoplasia. An update. J Reprod Med. 1993;38(3):186-8.